Search details
1.
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).
Cancer
; 2024 Apr 29.
Article
in English
| MEDLINE | ID: mdl-38682652
2.
Long-term Outcomes following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched Analysis.
Ann Surg
; 2024 Mar 22.
Article
in English
| MEDLINE | ID: mdl-38516777
3.
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study.
Br J Surg
; 111(4)2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38659247
4.
Bone loss over time and risk of osteoporosis in advanced pancreatic cancer.
Jpn J Clin Oncol
; 54(6): 667-674, 2024 Jun 01.
Article
in English
| MEDLINE | ID: mdl-38452123
5.
Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with Pancreatic Cancer.
Ann Surg
; 277(6): e1278-e1283, 2023 06 01.
Article
in English
| MEDLINE | ID: mdl-35081567
6.
Risk of Recurrence after Surgical Resection for Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasia (IPMN) with Patterns of Distribution and Treatment: An International, Multicentre, Observational Study.
Ann Surg
; 2023 Oct 24.
Article
in English
| MEDLINE | ID: mdl-37873663
7.
Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery.
Ann Surg Oncol
; 30(8): 5093-5102, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37140750
8.
Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel.
Pancreatology
; 23(3): 275-282, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36792473
9.
"Conversion surgery" for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022.
Pancreatology
; 23(6): 712-720, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37336669
10.
The impact of osteosarcopenia in patients with unresectable or recurrent biliary tract cancer receiving palliative chemotherapy.
Jpn J Clin Oncol
; 53(11): 1051-1057, 2023 Nov 05.
Article
in English
| MEDLINE | ID: mdl-37554052
11.
Outcomes of lung oligometastasis in pancreatic cancer.
Jpn J Clin Oncol
; 53(12): 1144-1152, 2023 Dec 07.
Article
in English
| MEDLINE | ID: mdl-37609670
12.
Long-term outcomes of duckbill-type anti-reflux metal stents versus conventional covered metal stents in reinterventions after covered biliary metal stent dysfunction in unresectable pancreatic cancer.
Surg Endosc
; 37(5): 3498-3506, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36581786
13.
Outcomes after partially covered self-expandable metal stent placement for recurrent duodenal obstruction.
Surg Endosc
; 37(1): 319-328, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35941307
14.
Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction.
Dig Dis Sci
; 68(4): 1139-1147, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36242688
15.
Endoscopic nasobiliary drainage versus endoscopic biliary stenting for preoperative biliary drainage in patients with malignant hilar biliary obstruction: Propensity score-matched multicenter comparative study.
Dig Endosc
; 2023 Oct 27.
Article
in English
| MEDLINE | ID: mdl-37885412
16.
Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels.
HPB (Oxford)
; 25(1): 100-108, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36280425
17.
KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer.
Cancer Sci
; 113(9): 3097-3109, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35567350
18.
Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study.
Ann Surg Oncol
; 29(8): 5038-5050, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35294658
19.
Early-onset pancreatic cancer: Clinical characteristics and survival outcomes.
Pancreatology
; 22(4): 507-515, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35422382
20.
Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers.
Helicobacter
; 27(1): e12866, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35005807